Press Releases :: Nighthawk Biosciences, Inc. (HTBX)

Oct 07, 2020 7:30am EDT

Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator

Sep 09, 2020 7:30am EDT

Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

Sep 02, 2020 7:30am EDT

Heat Biologics Issued Key Patent on Combination Platform Therapy

Aug 26, 2020 7:30am EDT

Heat Biologics Announces Publication of Preclinical COVID-19 Vaccine Results

Aug 13, 2020 7:00am EDT

Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies

Aug 07, 2020 7:00am EDT

Heat Biologics Provides Second Quarter 2020 Business Update

Aug 05, 2020 7:30am EDT

Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19

Jul 29, 2020 7:30am EDT

Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies

Jul 27, 2020 6:30am EDT

Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule

Jun 22, 2020 7:30am EDT

Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35

rss_feed News RSS

OUR ECOSYSTEM